Fundraising FoxFuture Planet Capital — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific immunotherapies designed to guide T cells to treat autoimmune and inflammatory diseases.
BiotechDeep TechHealthtechMedical Devices
Geoffrey Lynn(Chief Scientific Officer)inWilliam Enright(Chief Executive Officer & Board Director)Leon Hooftman(Chief Medical Officer)inBill EnrightinAdrian Hill(Founder)Sarah Gilbert(Founder)
Co-investorsGV (Google Ventures)Oxford Science EnterprisesGilead SciencesKorea Investment PartnersMilltrust International GroupTencent Holdings+1 more
BiotechBerkeley, US
Genine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)
Co-investorsBerkeley SkyDeck FundSolasta VenturesTachyon Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.